Gastrointestinal: Hepatic abscess after botulinum toxin type-A therapy for achalasia.

Giles, H; Ross, A; Gearry, R B

Giles, H; Ross, A; Gearry, R B.

Affiliation

Giles H; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
Ross A; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
Gearry RB; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.

J Gastroenterol Hepatol ; 32(10): 1663, 2017 Oct.

Article in En | MEDLINE | ID: mdl-28948702

Subject(s)

Botulinum Toxins, Type A/administration & dosage; Botulinum Toxins, Type A/adverse effects; Esophageal Achalasia/drug therapy; Liver Abscess/diagnostic imaging; Liver Abscess/etiology; Streptococcal Infections/diagnostic imaging; Streptococcal Infections/etiology; Streptococcus intermedius/isolation & purification; Administration, Oral; Ceftriaxone/administration & dosage; Diagnosis, Differential; Female; Humans; Infusions, Intravenous; Injections, Intralesional; Liver Abscess/drug therapy; Liver Abscess/microbiology; Metronidazole/administration & dosage; Middle Aged; Streptococcal Infections/drug therapy; Streptococcal Infections/microbiology; Tomography, X-Ray Computed; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Esophageal Achalasia / Botulinum Toxins, Type A / Streptococcus intermedius / Liver Abscess Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: J Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2017 Document type: Article Affiliation country: New Zealand Country of publication: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google